or Try an Advanced Search...

    Holdings

    Symbol Grade Price % Change Allocation
    NVO D 0.05 3.14
    NVS C 0.23 1.71
    TM F 2.06 1.36

    Represented by ETF Holdings

    Keywords: Active Pharmaceutical Ingredients Animal Health Anti Diabetic Drugs Antibiotics Auto Parts Automotive Industry Biopharmaceutical Biotechnology Blood Test Cars Contact Lens Contact Lenses Diabetes Diabetes Care Diagnostic Products Disposable Product Disposable Products Drugs E Commerce Marketplace Endocrine System
    Industries: Auto Manufacturers Biotechnology Drug Manufacturers - Major

    Recent News for EA Series Trust Strive International Developed Markets ETF & its Holdings

    Date Stock Title
    Sep 18 TM EVs Could Cost Kamala Harris the Election When They Shouldn’t Be Political
    Sep 18 NVO Sanders says generic drugmakers could sell Novo Nordisk Ozempic for less than $100
    Sep 18 NVO Multiple Strong Catalysts And Attractive Valuation Make Novo Nordisk A Buy
    Sep 18 NVS FDA expands Novartis’ Kisqali label to include early breast cancer patients
    Sep 18 TM Toyota Drives Student Success with $5.8 Million Investment in Northeast Mississippi
    Sep 18 NVS Weight loss drug pricing under fire with pills on the horizon
    Sep 18 TM Toyota Sienna gets millimetre wave radar rear seat reminder
    Sep 18 NVS Novartis Wins FDA Approval of Kisqali for Early Breast Cancer
    Sep 18 NVS Novartis’ Kisqali gets expanded FDA OK; Mene Pangalos joins Omega Funds
    Sep 18 TM Philippine sales continue to grow in August
    Sep 17 NVO Novo says Ozempic 'very likely' to be on 2027 Medicare negotiation list, Bloomberg News reports
    Sep 17 NVO Weight-loss drug competition heats up with growing pill market
    Sep 17 NVO Novo Nordisk says Ozempic a 'very likely' target in next Medicare drug pricing talks
    Sep 17 NVO US Senator Sanders says generic drugmakers could sell Ozempic for less than $100/month
    Sep 17 NVS Novartis Kisqali gains early breast cancer indication
    Sep 17 NVS FDA approves Novartis Kisqali® to reduce risk of recurrence in people with HR+/HER2- early breast cancer
    Sep 17 NVS Novartis' Kisqali Lowers Risk of Breast Cancer Recurrence by 28%
    Sep 17 TM Why FuelCell Energy Stock Jumped 9% Today
    Sep 17 TM Celebrate the Best of Toyota Highlander with Limited 25th Edition Hybrid
    Sep 17 TM Toyota Sienna Adds New Seat Reminder Tech and Interior Updates for 2025
    The fund seeks to track the investment results of the index, which tracks mid- and large- cap companies of developed market countries, not including the U.S., which are selected and weighted according to free-float market capitalization. Under normal circumstances, substantially all, but at least 80% of the fund"s total assets will be invested in developed markets securities.
    Index Fund MSCI EAFE
    Back to the Main STXI Page...